Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Poly Medicure Limited (NSE: POLYMED), ISIN INE205C01021 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
POLYMED last traded at ₹1601.65 (-0.66%), with a 52-week range of ₹1182.00 to ₹2094.30 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 62.42%, FIIs 5.36%, DIIs 15.90%, mutual funds 9.77%.
EquiSense Score (ECS): 67/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.